Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

IDEXX Laboratories, Inc. provides diagnostic, detection, and information systems for veterinary, food, and water testing applications. The Company also operates an international network of veterinary reference laboratories. IDEXX offers its products to customers worldwide.
Website: idexx.com



Growth: Good revenue growth rate 14.4%, there is acceleration compared to average historical growth rates 8.5%. The revenue growth dynamics is stable Site traffic for the last 3 months showed a change of +4.3%

Profitability: LTM EBITDA margin is positive, +34.3%. On average the margin is improving unsteadily. Gross margin is high, +61.8%. In the last quarter the company beat the estimated EPS, +5.4%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.07 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 0.9% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 93.3% higher than minimum and 9.0% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.7x by EV / Sales multiple , the company can be 72.0% overvalued

Insiders: For the last 3 months insiders sold company shares on $7.3 mln (-0.014% of cap.)

Key Financials (Download financials)

Ticker: IDXX
Share price, USD:  (0.0%)697.82
year average price 581.66  


year start price 444.53 2025-02-14

min close price 361.04 2025-04-08

max close price 766.68 2025-11-25

current price 697.82 2026-02-13
Common stocks: 79 898 000

Dividend Yield:  0.0%
FCF Yield LTM: 0.9%
EV / LTM EBITDA: 38.4x
EV / EBITDA annualized: 40.1x
Last revenue growth (y/y):  +14.4%
Last growth of EBITDA (y/y):  +18.1%
Historical revenue growth:  +8.5%
Historical growth of EBITDA:  +14.8%
EV / Sales: 13.2x
Margin (EBITDA LTM / Revenue): 34.3%
Fundamental value created in LTM:
Market Cap ($m): 55 754
Net Debt ($m): 868
EV (Enterprise Value): 56 622
Price to Book: 34.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-02-02seekingalpha.com

IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript

2026-02-02zacks.com

Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates

2026-02-02businesswire.com

IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results

2026-01-29zacks.com

3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)

2026-01-28zacks.com

Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings

2025-12-29zacks.com

Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?

2025-12-04zacks.com

IDEXX Laboratories Stock Rallies 75.6% YTD: What's Behind the Surge?

2025-11-28zacks.com

Idexx (IDXX) Upgraded to Buy: Here's What You Should Know

2025-11-28zacks.com

What Makes Idexx Laboratories (IDXX) a Strong Momentum Stock: Buy Now?

2025-11-21zacks.com

3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q4 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-12-31 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716
filingDate 2026-02-02 2025-02-21 2024-02-22 2023-02-16 2022-02-16 2021-02-12
acceptedDate 2026-02-02 06:39:21 2025-11-03 16:13:42 2025-08-04 16:22:36 2025-02-21 08:28:50 2024-10-31 16:14:44 2024-08-06 16:07:57 2024-05-01 16:13:57 2024-02-22 16:17:19 2023-11-01 16:20:22 2023-08-01 16:08:19 2023-05-02 16:02:30 2023-02-16 17:08:02 2022-11-01 16:33:30 2022-02-16 14:57:07 2021-02-12 15:22:33
fiscalYear 2025 2024 2023 2022 2021 2020
period FY Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 4 304M 1 105M 1 109M 3 898M 976M 1 004M 964M 3 661M 916M 944M 900M 3 367M 842M 3 215M 2 707M
costOfRevenue 1 644M 422M 415M 1 519M 380M 383M 371M 1 471M 368M 371M 357M 1 363M 335M 1 326M 1 136M
grossProfit 2 660M 683M 695M 2 379M 596M 621M 593M 2 190M 548M 573M 543M 2 004M 507M 1 889M 1 571M
researchAndDevelopmentExpenses 251M 63M 62M 220M 54M 55M 53M 191M 48M 47M 45M 255M 48M 161M 141M
generalAndAdministrativeExpenses 405M 106M 99M 442M 92M 157M 92M 336M 89M 90M 70M 326M 84M 310M 301M
sellingAndMarketingExpenses 644M 159M 161M 589M 146M 143M 149M 566M 136M 141M 148M 525M 130M 487M 434M
sellingGeneralAndAdministrativeExpenses 1 048M 265M 260M 1 031M 238M 300M 241M 902M 225M 230M 218M 851M 214M 796M 735M
otherExpenses 0 0 0 0 0 0 0 0 0 0 0 2M 0 1M 0
operatingExpenses 1 300M 329M 322M 1 251M 292M 355M 294M 1 093M 273M 277M 263M 1 106M 262M 957M 877M
costAndExpenses 2 944M 750M 736M 2 769M 672M 738M 665M 2 564M 640M 647M 620M 2 469M 597M 2 283M 2 012M
netInterestIncome -36M -19M -36M -39M -29M -33M
interestIncome 2M 580 000 627 000 13M 3M 3M 4M 6M 1M 327 000 416 000 1M 353 000 434 000 586 000
interestExpense 38M 11M 11M 31M 8M 8M 8M 42M -7M 10M 13M 40M 11M 30M 33M
depreciationAndAmortization 106M 37M 36M 130M 34M 32M 30M 115M 29M 28M 28M 112M 29M 105M 96M
ebitda 1 469M 392M 409M 1 276M 342M 301M 333M 1 218M 275M 296M 280M 1 015M 274M 1 040M 794M
ebit 1 362M 1 141M 1 103M 900M 932M 695M
nonOperatingIncomeExcludingInterest -2M -13M -6M -1M -434 000 -586 000
operatingIncome 1 360M 355M 373M 1 128M 304M 266M 299M 1 097M 275M 296M 280M 899M 245M 932M 695M
totalOtherIncomeExpensesNet -36M -10M -11M -19M -5M -5M -3M -36M -7M -10M -13M -39M -11M -29M -33M
incomeBeforeTax 1 324M 345M 362M 1 110M 299M 259M 295M 1 061M 268M 286M 268M 860M 234M 903M 662M
incomeTaxExpense 265M 70M 68M 222M 66M 56M 60M 216M 56M 62M 54M 181M 53M 158M 80M
netIncomeFromContinuingOperations 1 059M 888M 845M 679M 745M 582M
netIncomeFromDiscontinuedOperations 0 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0 0
netIncome 1 059M 275M 294M 888M 233M 203M 236M 845M 212M 224M 214M 679M 181M 745M 582M
netIncomeDeductions 0 0 0 0 0 0
bottomLineNetIncome 1 059M 888M 845M 679M 745M 582M
eps 13.17 3.43 3.66 10.77 2.83 2.46 2.84 10.17 2.55 2.7 2.58 8.12 2.17 8.74 6.82
epsDiluted 13.08 10.67 10.06 8.03 8.6 6.71
weightedAverageShsOut 80M 80M 80M 82M 82M 83M 83M 83M 83M 83M 83M 84M 83M 85M 85M
weightedAverageShsOutDil 81M 81M 81M 83M 83M 83M 84M 84M 84M 84M 84M 85M 84M 87M 87M
fillingDate 2025-11-03 2025-08-04 2024-10-31 2024-08-06 2024-05-01 2023-11-01 2023-08-01 2023-05-02 2022-11-01
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
grossProfitRatio 0.618 0.626 0.611 0.619 0.615 0.599 0.607 0.603 0.602
ebitdaratio 0.355 0.369 0.351 0.297 0.346 0.301 0.314 0.311 0.325
operatingIncomeRatio 0.321 0.336 0.312 0.265 0.31 0.301 0.314 0.311 0.291
incomeBeforeTaxRatio 0.312 0.327 0.306 0.258 0.306 0.293 0.303 0.297 0.278
netIncomeRatio 0.248 0.265 0.239 0.203 0.244 0.232 0.238 0.238 0.215
epsdiluted 3.4 3.63 2.8 2.44 2.81 2.53 2.67 2.55 2.15
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q4 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-12-31 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716
filingDate 2026-02-02 2025-02-21 2024-02-22 2023-02-16 2022-02-16 2021-02-12
acceptedDate 2026-02-02 06:39:21 2025-11-03 16:13:42 2025-08-04 16:22:36 2025-02-21 08:28:50 2024-10-31 16:14:44 2024-08-06 16:07:57 2024-05-01 16:13:57 2024-02-22 16:17:19 2023-11-01 16:20:22 2023-08-01 16:08:19 2023-05-02 16:02:30 2023-02-16 17:08:02 2022-11-01 16:33:30 2022-02-16 14:57:07 2021-02-12 15:22:33
fiscalYear 2025 2024 2023 2022 2021 2020
period FY Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 180M 208M 165M 288M 309M 402M 397M 454M 332M 133M 111M 113M 99M 144M 384M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 180M 208M 165M 288M 309M 402M 397M 454M 332M 133M 111M 113M 99M 144M 384M
netReceivables 552M 715M 663M 561M 587M 608M 578M 530M 453M 462M 446M 491M 475M 426M 375M
accountsReceivables 552M 534M 513M 442M 406M 355M
otherReceivables 0 27M 17M 48M 19M 19M
inventory 378M 392M 393M 382M 390M 380M 391M 380M 394M 395M 391M 368M 355M 269M 210M
prepaids 0 59M 48M 42M 42M 35M
otherCurrentAssets 304M 92M 142M 110M 148M 139M 34M 83M 206M 189M 201M 88M 129M 75M 60M
totalCurrentAssets 1 414M 1 407M 1 362M 1 400M 1 434M 1 469M 1 502M 1 495M 1 384M 1 179M 1 149M 1 101M 1 059M 956M 1 063M
propertyPlantEquipmentNet 747M 868M 869M 829M 839M 828M 829M 818M 687M 683M 665M 768M 723M 693M 646M
goodwill 0 414M 414M 405M 412M 408M 409M 366M 362M 364M 363M 362M 355M 359M 243M
intangibleAssets 0 115M 104M 112M 107M 111M 115M 85M 87M 91M 94M 98M 100M 99M 53M
goodwillAndIntangibleAssets 0 528M 518M 517M 519M 519M 524M 450M 449M 455M 457M 459M 455M 458M 296M
longTermInvestments 0 277M 58M 58M 55M 238M 54M 56M -459M -461M 54M 56M 52M 19M 12M
taxAssets 0 31M 125M 126M 135M 126M 107M 107M 11M 6M 6M 55M 52M 25M 32M
otherNonCurrentAssets 1 190M 275M 397M 364M 428M 235M 338M 333M 1 015M 1 009M 476M 307M 300M 287M 246M
totalNonCurrentAssets 1 937M 1 980M 1 968M 1 894M 1 976M 1 946M 1 852M 1 765M 1 702M 1 692M 1 659M 1 645M 1 581M 1 482M 1 232M
otherAssets 0 0 0 0 -59M 0 0 0 0 0 0 0 0 0 0
totalAssets 3 351M 3 387M 3 331M 3 293M 3 351M 3 415M 3 354M 3 260M 3 086M 2 871M 2 808M 2 747M 2 640M 2 437M 2 295M
totalPayables 110M 176M 197M 159M 159M 117M
accountPayables 110M 122M 117M 114M 111M 117M 117M 111M 113M 108M 118M 110M 110M 116M 75M
otherPayables 0 62M 87M 49M 43M 43M
accruedExpenses 0 244M 198M 222M 213M 188M
shortTermDebt 473M 632M 680M 418M 370M 440M 344M 325M 400M 339M 506M 654M 652M 148M 50M
capitalLeaseObligationsCurrent 0 22M 20M 20M 20M 18M
taxPayables 0 0 75M 62M 80M 146M 134M 87M 50M 82M 73M 49M 35M 43M 43M
deferredRevenue 35M 36M 36M 34M 38M 38M 38M 37M 37M 38M 38M 38M 41M 40M 43M
otherCurrentLiabilities 530M 462M 316M 175M 410M 375M 457M 174M 420M 399M 404M 143M 387M 183M 168M
totalCurrentLiabilities 1 149M 1 252M 1 224M 1 068M 1 009M 1 117M 957M 952M 970M 884M 1 066M 1 236M 1 190M 764M 583M
longTermDebt 375M 481M 557M 450M 628M 628M 725M 623M 619M 697M 696M 694M 854M 775M 858M
capitalLeaseObligationsNonCurrent 0 98M 100M 101M 87M 77M
deferredRevenueNonCurrent 0 31M 32M 27M 27M 27M 28M 29M 28M 29M 30M 31M 35M 41M 46M
deferredTaxLiabilitiesNonCurrent 0 4M 2M 11M 6M 10M 9M 7M -28M -29M 6M 8M 14M 9M 12M
otherNonCurrentLiabilities 222M 58M 57M 44M 63M 53M 66M 66M 200M 196M 169M 68M 171M 71M 86M
totalNonCurrentLiabilities 597M 574M 648M 630M 723M 718M 828M 824M 819M 893M 902M 902M 974M 984M 1 079M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 106M 133M 119M 124M 123M 123M 119M 101M 97M 98M 122M 112M 107M 95M
totalLiabilities 1 745M 1 826M 1 872M 1 698M 1 733M 1 835M 1 785M 1 775M 1 789M 1 777M 1 967M 2 138M 2 164M 1 747M 1 662M
treasuryStock 0 -5 334M -4 475M -4 392M -3 571M -2 800M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 0 11M 11M 11M 11M 11M 11M 11M 11M 11M 11M 11M 11M 11M 11M
retainedEarnings 0 6 144M 5 869M 5 332M 5 116M 4 883M 4 680M 4 445M 4 250M 4 038M 3 814M 3 600M 3 427M 2 920M 2 176M
additionalPaidInCapital 0 1 674M 1 570M 1 463M 1 377M 1 295M
accumulatedOtherComprehensiveIncomeLoss 0 -67M -77M -94M -70M -79M -80M -71M -75M -74M -77M -78M -81M -53M -54M
otherTotalStockholdersEquity 1 605M 6M 6M 5M 6M 5M
totalStockholdersEquity 1 605M 1 561M 1 459M 1 595M 1 618M 1 580M 1 569M 1 485M 1 297M 1 094M 841M 609M 476M 690M 632M
totalEquity 1 605M 1 561M 1 459M 1 595M 1 618M 1 580M 1 569M 1 485M 1 297M 1 094M 841M 609M 476M 690M 633M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 707 000
totalLiabilitiesAndTotalEquity 3 351M 3 387M 3 331M 3 293M 3 351M 3 415M 3 354M 3 260M 3 086M 2 871M 2 808M 2 747M 2 640M 2 437M 2 295M
totalInvestments 0 277M 58M 58M 55M 238M 54M 56M -459M -461M 54M 56M 52M 19M 12M
totalDebt 848M 1 113M 1 237M 987M 998M 1 068M 1 069M 1 067M 1 019M 1 036M 1 203M 1 470M 1 506M 1 031M 1 003M
netDebt 668M 905M 1 073M 699M 690M 666M 672M 613M 687M 903M 1 091M 1 357M 1 407M 887M 619M
fillingDate 2025-11-03 2025-08-04 2024-10-31 2024-08-06 2024-05-01 2023-11-01 2023-08-01 2023-05-02 2022-11-01
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
othertotalStockholdersEquity -4 527M -4 344M -3 439M -3 235M -3 042M -2 888M -2 881M -2 907M -2 881M
totalLiabilitiesAndStockholdersEquity 3 387M 3 331M 3 351M 3 415M 3 354M 3 086M 2 871M 2 808M 2 640M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link

Cash Flow Statement

Property 2025 q4 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-12-31 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX IDXX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716 874 716
filingDate 2026-02-02 2025-02-21 2024-02-22 2023-02-16 2022-02-16 2021-02-12
acceptedDate 2026-02-02 06:39:21 2025-11-03 16:13:42 2025-08-04 16:22:36 2025-02-21 08:28:50 2024-10-31 16:14:44 2024-08-06 16:07:57 2024-05-01 16:13:57 2024-02-22 16:17:19 2023-11-01 16:20:22 2023-08-01 16:08:19 2023-05-02 16:02:30 2023-02-16 17:08:02 2022-11-01 16:33:30 2022-02-16 14:57:07 2021-02-12 15:22:33
fiscalYear 2025 2024 2023 2022 2021 2020
period FY Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 1 059M 275M 294M 888M 233M 203M 236M 845M 212M 224M 214M 679M 181M 745M 582M
depreciationAndAmortization 0 -104M 70M 130M 34M 32M 30M 115M 29M 28M 28M 112M 29M 105M 96M
deferredIncomeTax 0 -10M 6M -24M -7M -19M -3M -48M -2M -9M -4M -35M -13M -3M -38M
stockBasedCompensation 0 -44M 29M 60M 16M 16M 14M 60M 15M 15M 14M 50M 13M 38M 31M
changeInWorkingCapital -228M 225M -164M -133M -57M 14M -81M -72M 16M -60M -71M -274M -23M -138M -32M
accountsReceivables 0 75M -30M -28M 27M -29M -54M -54M 7M -17M -44M -41M 19M -33M -61M
inventory 0 4M -6M -28M 6M -4M -2M -29M 7M -15M -24M -122M -50M -53M -19M
accountsPayables 0 12M -4M 8M -1M 8M -4M -557 000 -3M -7M 3M 3M 3M 11M 981 000
otherWorkingCapital -228M 133M -124M -85M -89M 39M -21M 11M 5M -20M 65M -114M 6M -63M 47M
otherNonCashItems 350M 62M -50M 8M 1M 107M 909 000 8M 2M 2M 2M 11M 3M 9M 9M
netCashProvidedByOperatingActivities 1 182M 402M 186M 929M 220M 248M 199M 907M 272M 200M 184M 543M 189M 756M 648M
investmentsInPropertyPlantAndEquipment -125M -31M -34M -121M -28M -33M -30M -134M -34M -27M -40M -149M -38M -120M -108M
acquisitionsNet -14M 0 0 -78M 306 000 0 -77M 0 0 0 0 -47M -12M -173M -2M
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 -25M 0 0 0
salesMaturitiesOfInvestments 0 0 0 2M -727 000 398 000 329 000 0 0 0 0 72M 0 0 0
otherInvestingActivities 3M -10M 8M -47M 0 0
netCashProvidedByInvestingActivities -136M -207M -125M -195M -293M -109M
netDebtIssuance -30M -75M -404M 431M 24M -95M
longTermNetDebtIssuance -178M -75M -75M -75M -50M 195M
shortTermNetDebtIssuance 148M 0 -329M 506M 74M -290M
netStockIssuance -1 124M -793M -25M -784M -700M -131M
netCommonStockIssuance -1 124M -793M -25M -784M -700M -131M
commonStockIssuance 93M 44M 47M 36M 47M 51M
commonStockRepurchased -1 217M -240M -338M -837M -221M -216M -155M -72M -35M -10M 0 -820M -173M -747M -183M
netPreferredStockIssuance 0 0 0 0 0 0
netDividendsPaid 0 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0 0
otherFinancingActivities -11M -11M -13M -17M -21M -22M
netCashProvidedByFinancingActivities -1 165M -878M -442M -371M -697M -248M
effectOfForexChangesOnCash 11M -587 000 14M -10M 5M -1M -4M 2M -3M -340 000 501 000 -9M -6M -5M 3M
netChangeInCash -108M 44M 624 000 -166M -93M 4M -56M 341M 199M 21M -1M -32M -15M -239M 294M
cashAtEndOfPeriod 180M 208M 165M 288M 309M 402M 397M 454M 332M 133M 111M 113M 99M 144M 384M
cashAtBeginningOfPeriod 288M 165M 164M 454M 402M 397M 454M 113M 133M 111M 113M 144M 114M 384M 90M
operatingCashFlow 1 182M 402M 186M 929M 220M 248M 199M 907M 272M 200M 184M 543M 189M 756M 648M
capitalExpenditure -125M -31M -34M -131M -28M -33M -30M -134M -34M -27M -40M -149M -38M -120M -108M
freeCashFlow 1 057M 371M 152M 798M 192M 215M 168M 773M 238M 173M 144M 394M 151M 636M 540M
incomeTaxesPaid 0 0 0 0 0 0
interestPaid 0 0 0 0 0 0
fillingDate 2025-11-03 2025-08-04 2024-10-31 2024-08-06 2024-05-01 2023-11-01 2023-08-01 2023-05-02 2022-11-01
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
otherInvestingActivites -14M 474 000 1M 398 000 329 000 6M 0 0 0
netCashUsedForInvestingActivites -45M -34M -27M -33M -107M -28M -27M -40M -49M
debtRepayment 0 156M -75M 0 0 -14M 0 0 0
commonStockIssued -25M 17M 0 0 21M 13M 0 13M 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -49M -970 000 5M 5M -10M -5M -141M -159M 24M
netCashUsedProvidedByFinancingActivities -313M -166M -291M -210M -144M -43M -151M -146M -149M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link

Earning call transcript

2025 q4
2026-02-02 ET (fiscal 2025 q4)
2025 q3
2025-11-03 ET (fiscal 2025 q3)
2025 q2
2025-08-04 ET (fiscal 2025 q2)
2025 q1
2025-05-01 ET (fiscal 2025 q1)
2024 q4
2025-02-03 ET (fiscal 2024 q4)
2024 q3
2024-10-31 ET (fiscal 2024 q3)
2024 q2
2024-08-06 ET (fiscal 2024 q2)
2024 q1
2024-05-01 ET (fiscal 2024 q1)
2023 q4
2024-02-05 ET (fiscal 2023 q4)
2023 q3
2023-11-01 ET (fiscal 2023 q3)
2023 q2
2023-08-01 ET (fiscal 2023 q2)
2023 q1
2023-05-02 ET (fiscal 2023 q1)
2022 q4
2023-02-06 ET (fiscal 2022 q4)
2022 q3
2022-11-01 ET (fiscal 2022 q3)
2022 q2
2022-08-02 ET (fiscal 2022 q2)
2022 q1
2022-05-04 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2026-02-02 06:39 ET
IDEXX Laboratories reported for 2025 q4
SEC form 8
2026-02-02 06:39 ET
IDEXX Laboratories published news for 2025 q4
SEC form 10
2025-11-03 16:13 ET
IDEXX Laboratories reported for 2025 q3
SEC form 8
2025-11-03 06:34 ET
IDEXX Laboratories reported for 2025 q3
SEC form 8
2025-11-03 06:34 ET
IDEXX Laboratories published news for 2025 q3
SEC form 10
2025-08-04 20:22 ET
IDEXX Laboratories reported for 2025 q2
SEC form 8
2025-08-04 10:30 ET
IDEXX Laboratories reported for 2025 q2
SEC form 8
2025-08-04 10:30 ET
IDEXX Laboratories published news for 2025 q2
SEC form 10
2025-05-01 20:11 ET
IDEXX Laboratories published news for 2025 q1
SEC form 8
2025-05-01 10:30 ET
IDEXX Laboratories reported for 2025 q1
SEC form 8
2025-05-01 10:30 ET
IDEXX Laboratories published news for 2025 q1
SEC form 10
2025-05-01 00:00 ET
IDEXX Laboratories published news for 2025 q1
SEC form 10
2025-02-21 13:28 ET
IDEXX Laboratories published news for 2024 q4
SEC form 10
2025-02-21 00:00 ET
IDEXX Laboratories published news for 2024 q4
SEC form 8
2025-02-03 06:30 ET
IDEXX Laboratories published news for 2024 q4
SEC form 8
2025-02-03 06:30 ET
IDEXX Laboratories reported for 2024 q4
SEC form 10
2024-10-31 16:14 ET
IDEXX Laboratories reported for 2024 q3
SEC form 8
2024-10-31 13:23 ET
IDEXX Laboratories reported for 2024 q3
SEC form 8
2024-10-31 13:23 ET
IDEXX Laboratories published news for 2024 q3
SEC form 8
2024-10-31 06:30 ET
IDEXX Laboratories published news for 2024 q3
SEC form 8
2024-10-31 06:30 ET
IDEXX Laboratories published news for 2024 q3
SEC form 10
2024-10-31 00:00 ET
IDEXX Laboratories reported for 2024 q3
SEC form 10
2024-08-06 16:07 ET
IDEXX Laboratories published news for 2024 q2
SEC form 8
2024-08-06 06:30 ET
IDEXX Laboratories published news for 2024 q2
SEC form 8
2024-08-06 06:30 ET
IDEXX Laboratories reported for 2024 q2
SEC form 10
2024-08-06 00:00 ET
IDEXX Laboratories published news for 2024 q2
SEC form 10
2024-05-01 16:13 ET
IDEXX Laboratories published news for 2024 q1
SEC form 8
2024-05-01 06:30 ET
IDEXX Laboratories published news for 2024 q1
SEC form 8
2024-05-01 06:30 ET
IDEXX Laboratories reported for 2024 q1
SEC form 10
2024-05-01 00:00 ET
IDEXX Laboratories published news for 2024 q1
SEC form 10
2024-02-22 00:00 ET
IDEXX Laboratories published news for 2023 q4
SEC form 8
2024-02-05 00:00 ET
IDEXX Laboratories reported for 2023 q4
SEC form 8
2024-02-05 00:00 ET
IDEXX Laboratories published news for 2023 q4
SEC form 10
2023-11-01 16:20 ET
IDEXX Laboratories published news for 2023 q3
SEC form 8
2023-11-01 06:30 ET
IDEXX Laboratories reported for 2023 q3
SEC form 10
2023-11-01 00:00 ET
IDEXX Laboratories published news for 2023 q3
SEC form 10
2023-08-01 16:08 ET
IDEXX Laboratories published news for 2023 q2
SEC form 6
2023-08-01 06:30 ET
IDEXX Laboratories reported for 2023 q2
SEC form 8
2023-08-01 00:00 ET
IDEXX Laboratories published news for 2023 q2
SEC form 10
2023-08-01 00:00 ET
IDEXX Laboratories published news for 2023 q2
SEC form 6
2023-07-12 17:00 ET
IDEXX Laboratories published news for 2023 q2
SEC form 6
2023-07-12 07:01 ET
IDEXX Laboratories published news for 2023 q2
SEC form 8
2023-05-02 00:00 ET
IDEXX Laboratories published news for 2023 q1
SEC form 10
2023-05-02 00:00 ET
IDEXX Laboratories published news for 2023 q1
SEC form 10
2023-02-16 17:08 ET
IDEXX Laboratories reported for 2022 q4
SEC form 10
2023-02-16 00:00 ET
IDEXX Laboratories reported for 2022 q4
SEC form 6
2023-02-06 06:31 ET
IDEXX Laboratories published news for 2022 q4
SEC form 8
2023-02-06 00:00 ET
IDEXX Laboratories published news for 2022 q4
SEC form 10
2022-11-01 16:33 ET
IDEXX Laboratories reported for 2022 q3
SEC form 6
2022-11-01 06:59 ET
IDEXX Laboratories published news for 2022 q3
SEC form 10
2022-11-01 00:00 ET
IDEXX Laboratories reported for 2022 q3
SEC form 8
2022-11-01 00:00 ET
IDEXX Laboratories published news for 2022 q3
SEC form 6
2022-10-21 16:36 ET
IDEXX Laboratories published news for 2022 q3
SEC form 10
2022-08-02 15:01 ET
IDEXX Laboratories reported for 2022 q2
SEC form 6
2022-08-02 06:31 ET
IDEXX Laboratories published news for 2022 q2
SEC form 8
2022-08-02 00:00 ET
IDEXX Laboratories published news for 2022 q2
SEC form 10
2022-08-02 00:00 ET
IDEXX Laboratories reported for 2022 q2
SEC form 6
2022-07-15 16:59 ET
IDEXX Laboratories published news for 2022 q2
SEC form 6
2022-06-14 16:30 ET
IDEXX Laboratories published news for 2022 q1
SEC form 6
2022-05-13 16:00 ET
IDEXX Laboratories published news for 2022 q1
SEC form 10
2022-05-04 14:57 ET
IDEXX Laboratories reported for 2022 q1
SEC form 6
2022-05-04 06:31 ET
IDEXX Laboratories published news for 2022 q1
SEC form 8
2022-05-04 00:00 ET
IDEXX Laboratories published news for 2022 q1
SEC form 10
2022-05-04 00:00 ET
IDEXX Laboratories reported for 2022 q1
SEC form 6
2022-03-31 16:01 ET
IDEXX Laboratories published news for 2021 q4
SEC form 6
2022-03-17 17:00 ET
IDEXX Laboratories published news for 2021 q4
SEC form 10
2022-02-16 14:57 ET
IDEXX Laboratories published news for 2021 q4
SEC form 10
2022-02-16 00:00 ET
IDEXX Laboratories published news for 2021 q4
SEC form 6
2022-02-02 06:30 ET
IDEXX Laboratories published news for 2021 q4
SEC form 8
2022-02-02 00:00 ET
IDEXX Laboratories published news for 2021 q4
SEC form 6
2021-12-09 16:15 ET
IDEXX Laboratories published news for 2021 q3
SEC form 10
2021-11-02 14:21 ET
IDEXX Laboratories published news for 2021 q3
SEC form 6
2021-11-02 06:33 ET
IDEXX Laboratories published news for 2021 q3
SEC form 10
2021-11-02 00:00 ET
IDEXX Laboratories published news for 2021 q3
SEC form 8
2021-11-02 00:00 ET
IDEXX Laboratories published news for 2021 q3
SEC form 6
2021-09-03 17:01 ET
IDEXX Laboratories published news for 2021 q2
SEC form 10
2021-07-30 14:48 ET
IDEXX Laboratories published news for 2021 q2
SEC form 6
2021-07-30 06:38 ET
IDEXX Laboratories published news for 2021 q2
SEC form 10
2021-07-30 00:00 ET
IDEXX Laboratories published news for 2021 q2
SEC form 8
2021-07-30 00:00 ET
IDEXX Laboratories published news for 2021 q2
SEC form 6
2021-05-18 17:01 ET
IDEXX Laboratories published news for 2021 q1
SEC form 10
2021-05-04 16:12 ET
IDEXX Laboratories published news for 2021 q1
SEC form 6
2021-05-04 06:30 ET
IDEXX Laboratories published news for 2021 q1
SEC form 10
2021-05-04 00:00 ET
IDEXX Laboratories published news for 2021 q1
SEC form 8
2021-05-04 00:00 ET
IDEXX Laboratories published news for 2021 q1
SEC form 6
2021-03-31 16:02 ET
IDEXX Laboratories published news for 2020 q4
SEC form 10
2021-02-12 15:22 ET
IDEXX Laboratories published news for 2020 q4
SEC form 6
2021-02-10 16:30 ET
IDEXX Laboratories published news for 2020 q4
SEC form 6
2021-02-02 06:31 ET
IDEXX Laboratories published news for 2020 q4
SEC form 6
2020-11-20 17:03 ET
IDEXX Laboratories published news for 2020 q3
SEC form 6
2020-11-12 07:31 ET
IDEXX Laboratories published news for 2020 q3
SEC form 6
2020-11-10 19:02 ET
IDEXX Laboratories published news for 2020 q3
SEC form 10
2020-10-29 15:43 ET
IDEXX Laboratories published news for 2020 q3
SEC form 6
2020-10-29 06:31 ET
IDEXX Laboratories published news for 2020 q3